Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Media kit
Innovation Awards
Home
BMS to pull Tequin antibiotic from the shelves
May 1, 2006
The
Washington Post
reports that Tequin is being
withdrawn from the market
, due to blood sugar complications that it can cause.
pharmamanufacturing
The
Washington Post
reports that Tequin is being
withdrawn from the market
, due to blood sugar complications that it can cause.
About the Author
pharmamanufacturing | pharmamanufacturing
Latest from Home
CDMO sector looks to recovery in 2025 amid positive macro, industry trends
Key drugs losing patent protection in 2025
Michael Annino / Shutterstock AI
Going above and beyond
Pittsburgh’s biotech leap
Michael Annino/Shutterstock AI
Pharma’s new age of longevity
Notable 2024 FDA decisions
Load More Content